A protein quality control pathway regulated by linear ubiquitination

Area of Science:

• Molecular Biology
• Neuroscience
• Cell Biology

Background:

• Neurodegenerative diseases involve misfolded protein accumulation, leading to neuronal dysfunction and death.
• Understanding protein quality control is key to developing effective therapies for these conditions.

Purpose of the Study:

• To investigate the role of the linear ubiquitin chain assembly complex (LUBAC) in protein quality control.
• To explore linear ubiquitination as a therapeutic target for proteinopathies.

Main Methods:

• Investigated the modification of disease-associated protein aggregates by LUBAC.
• Examined the recruitment of HOIP to misfolded Huntingtin and the subsequent assembly of linear polyubiquitin.
• Assessed the impact of silencing OTULIN and HOIP on proteotoxicity.

Main Results:

• Disease-associated protein aggregates are modified by LUBAC.
• HOIP recruitment to misfolded Huntingtin leads to linear polyubiquitin assembly, shielding protein surfaces and promoting proteasomal degradation.
• Sp1 regulates LUBAC components, linking LUBAC expression defects to Huntington's disease.
• Silencing OTULIN reduces proteotoxicity, while silencing HOIP increases it, supporting a protective role for linear ubiquitination.

Conclusions:

• Linear ubiquitination functions as a critical protein quality control mechanism.
• LUBAC and linear ubiquitination represent novel therapeutic targets for proteinopathies, including neurodegenerative diseases.